Chen Zhi Selected Research

E2F4 Transcription Factor

1/2021

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chen Zhi Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 09/2009
2	Hepatitis B 01/2021 - 01/2019
1	End Stage Liver Disease 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Failure 01/2021
1	Disease Progression 01/2019
1	Chronic Hepatitis B 01/2019
1	Brain Edema (Cerebral Edema) 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Cerebral Hemorrhage 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013
1	Lordosis 05/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 02/2015 - 11/2013
2	PDZ-binding kinaseIBA 02/2015 - 11/2013
1	Biological ProductsIBA 01/2021
1	Cytidine Triphosphate (CTP)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	E2F4 Transcription FactorIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2017
1	CannabinoidsIBA 01/2017
1	Neuroprotective AgentsIBA 01/2017

Therapy/Procedure

1	Therapeutics 01/2019
1	Laminectomy 05/2013
1	Craniotomy 09/2009